CANCELED - Lecture on Fibromyalgia and Migraines to Public April 7
**As of April 5, 2016, this event has been canceled**
The University of Cincinnati Neuroscience Institute and Department of Psychiatry and Behavioral Neuroscience present a lecture series on "Fibromyalgia and Migraines from 6:30 8:30 p.m. Thursday, April 7, in Room 2108 of the Stetson building, 260 Stetson St.
The program features the following speakers and presentations:
- "Juvenile Fibromyalgia: Whats New? by Tracy Ting, MD, assistant professor, UC Department of Pediatrics; Cincinnati Childrens Hospital Medical Center.
- "Update on Migraine by Vincent Martin, MD, professor of medicine and the director of the Headache and Facial Pain Program at the University of Cincinnati Neuroscience Institute, who has published extensive research on the topic of migraines. Martin is the president of the Ohio Headache Association and vice president of the National Headache Foundation.
Presentation moderator will be Lesley Arnold, MD, professor in the Department of Psychiatry and Behavioral Neuroscience and director of the Womens Health Research Program. Arnold has led numerous studies on the treatment of fibromyalgia.
Lesley Arnold, MD
Tags
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.
Driven by her own pain
March 8, 2026
Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of the uterus grows outside of it, causing pain, inflammation and sometimes infertility. Now a University of Cincinnati College of Medicine researcher is developing what is believed to be the first at-home diagnostic test.